Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
Clinical trial NCT02842749 · COMPLETED
Trial details
- NCT number
- NCT02842749
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-14
- Primary completion
- 2024-02-22
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.